An "exacerbate-reverse" strategy in yeast identifies histone deacetylase inhibition as a correction for cholesterol and sphingolipid transport defects in human Niemann-Pick type C disease (Q35085026)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An "exacerbate-reverse" strategy in yeast identifies histone deacetylase inhibition as a correction for cholesterol and sphingolipid transport defects in human Niemann-Pick type C disease |
scientific article |
Statements
1 reference
An "exacerbate-reverse" strategy in yeast identifies histone deacetylase inhibition as a correction for cholesterol and sphingolipid transport defects in human Niemann-Pick type C disease (English)
1 reference
Andrew B Munkacsi
1 reference
Fannie W Chen
1 reference
Matthew A Brinkman
1 reference
Katsumi Higaki
1 reference
Giselle DomÃnguez Gutiérrez
1 reference
Jagruti Chaudhari
1 reference
Jacob V Layer
1 reference
Amy Tong
1 reference
Martin Bard
1 reference
Charles Boone
1 reference
Yiannis A Ioannou
1 reference
Stephen L Sturley
1 reference
13 April 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference